Interestingly, Sox2 (stem cell marker) and miRNA-21 are expressed in mutually exclusive patterns in GBM (i.e., high miRNA-21/low Sox2 and low miRNA-21/high Sox2), indicating the existence of two populations of GBM patients with distinct phenotypic features and clinical outcomes. This evidence concerns the gene SOX2 and glioblastoma.